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Background: Attention deficit hyperactivity disorder (ADHD) is a chronic and progressive mental disorder related 
to the childhood period. This study aims to compare the oral health of two groups of ADHD children: those under 
pharmacotherapy and those under neuro-feedback therapy.
Material and Methods: 72 ADHD children (aged 6–12) were divided into two 36 member groups: The pharmaco-
therapy group and the neuro-feedback therapy group. Unstimulated salivary flow (USF), DMFT, and plaque index 
were assessed in these children. Statistical analysis was carried out on the data with the independent t-test, which 
was performed using SPSS 16. The significance level of the study was p<0.05. 
Results: In this study, the USF of ADHD children who used Ritalin was found to be significantly less than that of 
the neuro-feedback group (1.25 ± 1.21 vs. 1.91 ± 1.16 ml/min; p=0.002). Also, the plaque index (5.9 ± 3.1 vs. 3.94 
± 1.9; p=0.018) and DMFT scores (39% ± 9% vs. 31% ± 9%; p=0.018) were significantly higher for the pharma-
cotherapy group.
Conclusions: Neuro-feedback therapy is preferable to Ritalin treatment for ADHD children in terms of their oral 
health status.
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Introduction
Attention deficit hyperactivity disorder (AHDH) is a 
chronic and progressive mental disorder related to the 
childhood period. An evident characteristic is the mani-
festation of actions unrelated to the age of the individual 
such as unrest, doing things or acting without taking 
situations into account, weak organizational beha-
viors, and the inability to concentrate. Around 3–7% of 
school-aged children are affected by this disorder (1,2). 
Environmental and genetic factors are involved in the 
accession of ADHD, which leads to a disruption in the 
operation of dopamine which is a neurotransmitter that 
influences behaviors like risk-taking and irritability (3).
Treatment of ADHD generally includes combining phar-
macotherapy and behavioral-cognitive methods. Althou-
gh the frontline of the therapy consists of chemical me-
dicines, nowadays non-medicinal methods are favored 
more due to the side effects caused by drugs, parents’ 
negative attitude toward medicines, and the probability 
of the illness recurring after medicine consumption is 
terminated (4-6). The following are the most prominent 
non-medicinal methods: Acknowledging and rewarding 
appropriate behaviors, proper framing of the child’s mind, 
cognitive-perceptual interventions like neuro-feedback, 
yoga, meditation etc. Among these, the neuro-feedback 
therapy method has shown a higher success rate in trea-
ting ADHD (7). Recent studies have indicated that combi-
ned therapies (behavioral-therapy and pharmacotherapy) 
may eliminate the need for high drug doses (8). 
The frontline of pharmacotherapy for ADHD consists 
of Methylphenidate (Ritalin) and Dextroamphetamine. 
Other drugs used to treat this disorder include Bupro-
pion, Risperidone, and tri-cyclic antidepressants (TCA)
(9-11). Ritalin is an indirect agonist for dopamine that 
operates by preventing dopamine from recapturing (1), 
and is known to have many side effects such as xeros-
tomia and reduced secretion of saliva which lead to ex-
tensive dental caries. However, no consensus has been 
achieved on this issue. Friedlander AH and Friedlan-
der IK showed that pharmacotherapy by Ritalin is not 
effective on saliva flow (12). On the other hand, Hidas 
et al. found a significant difference in saliva flow, plaque 
index, and dental caries among ADHD children/adults 
under Ritalin treatment and those who were not under 
pharmacotherapy. Meanwhile, the saliva flow was ge-
nerally lower in ADHD children as compared to normal 
subjects (13, 14). 
Considering that no consensus has been attained in the 
above mentioned studies about the oral side effects of 
Ritalin in ADHD children, the following question ari-
ses: “Are reduced saliva flow and oral side effects the 
result of the illness itself or due to the pharmacothera-
py”? Therefore, this paper investigated oral health status 
(as indicated by DMFT, plaque index, and unstimulated 
saliva flow) in ADHD children under pharmacotherapy 
(Ritalin) and ADHD children under non-medicinal the-
rapeutic methods (neuro-feedback therapy).
Material and Methods
This cross-sectional/comparative study was performed 
during September 2015–April 2017 on ADHD children, 
aged 6–12 years, who were referred to the professio-
nal psychiatric clinics of Tabriz University of Medical 
Sciences. The study protocol was explained fully to the 
parents/legal guardians, and written informed consents 
were obtained. The study design was in accordance with 
the Helsinki Declaration on Ethical Principles for Medi-
cal Research Involving Human Subjects and was inde-
pendently reviewed and approved by the Committee for 
Research Ethics at Tabriz University of Medical Scien-
ces (Ref number: TBZMED.REC.1394.1076).
Considering α=0.05, power = 80% (15) and 10% diffe-
rence in unstimulated saliva flow between children un-
der treatment with Ritalin and neuro-feedback therapy 
(13), a required sample size of 32 was calculated for 
each group. ADHD in children attending psychiatric cli-
nics was identified by a child and adolescent psychiatrist 
as per DSM-IV-TR and was approved by K-SADS. The 
K-SADS is a semi-structured diagnostic interview for 
children and adolescents aged 6 to 18 years, based on 
the DSM-IV diagnostic criteria (16).  Of the visited chil-
dren diagnosed with ADHD, 36 children who were only 
under Ritalin treatment for six months were randomly 
selected as Group 1. Then, 36 other children who were 
under only neuro-feedback therapy according to the Lin-
den M. study (17) (40 sessions of 45 minutes each of 
neuro-feedback therapy for six months) were randomly 
classified as Group 2. The ADHD children who were un-
der no treatment or used another medicine (other than 
Ritalin) and those who had systemic or metabolic spe-
cial diseases were excluded from the study. 
-Assessment of Unstimulated saliva flow 
Total unstimulated saliva flow was analyzed in accor-
dance with Aframian et al. (accumulating the saliva in 
the mouth for five minutes and spitting in a glass) (18) 
and classified as low, very low, and normal according to 
Ericson and Hardwick (19). Owing to the possible effects 
of environmental conditions and the time of sampling on 
the saliva flow (circadian rhythm) samples were taken 
from all the participants under the same conditions, i.e., 
between 8 and 12 a.m.in a calm room (20,21). Also, the 
participants were prevented from eating, drinking, brus-
hing their teeth, or rinsing their mouth for at least one 
hour before collecting their saliva.
-Assessment of DMFT/dmft and plaque indices in the 
two groups
DMFT/dmft index was determined by a common me-
thod—using a mouth mirror and dental explorer under 
ample light (22). Plaque accumulation was analyzed by 
the O’Leary plaque index (23). 
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-Statistical analysis
The variables were described using mean and standard 
deviation (SD) and were evaluated by the Kolmogo-
rov-Smirnov test and Q-Q plot to check the normal dis-
tribution of data. Levene’s test was used to assess the 
equality of variances (24,25). The data obtained from 
the study variables was statistically analyzed with inde-
pendent t-test using the SPSS16 software (26). P<0.05 
was considered significant in this study.
Results 
A total of 18 girls and 52 boys with a mean age of 9.8 ± 
3.1 years were included into the study.
The mean and standard deviation of USF in ADHD chil-
dren under Ritalin treatment was 1.25 ± 1.21 ml/min. 
This figure was 1.91 ± 1.16 ml/min in children receiving 
neuro-feedback therapy (Fig.1, Table 1). The results of 
Fig. 1: Mean and standard deviation of USF in ADHD children in 
the study groups.
 
 n Mean SD 
Ritalin treatment 36 1.25 1.21 





Table 1: Mean and standard deviation of USF in ADHD children in 
the study groups.
the independent t-test showed that the USF of the ADHD 
children under Ritalin treatment was significantly less 
than the other group (p=0.002). 
The mean and standard deviation of DMFT/dmft sco-
res in ADHD children under Ritalin treatment was 5.9 ± 
3.1. This figure was 3.94 ± 1.9 in children receiving neu-
ro-feedback therapy (Fig. 2, Table 2). The results of the 
independent t-test showed that the DMFT/dmft scores 
Fig. 2: Mean and standard deviation of DMFT scores in ADHD chil-
dren in the study groups.
 
 n Mean SD 
Ritalin treatment 36 5.90 1.3 
Neuro-feedback therapy 36 3.94 1.9 
	
Table 2: Mean and standard deviation of DMFT scores in ADHD 
children in the study groups.
of the ADHD children under Ritalin treatment was sig-
nificantly higher than the neuro-feedback therapy group 
(p=0.008). 
Table 3 and Figure 3 show he mean and standard devia-
tion of the plaque index for both groups. The results of 
the independent t-test showed that the ADHD children 
under Ritalin treatment have significantly higher plaque 
index compared to those under neuro-feedback therapy 
(39% ± 9% vs. 31% ± 9%, p=0.018).
Discussion
This study aimed to compare the oral health of ADHD 
children under pharmacotherapy and neuro-feedback 
therapy. The initial symptoms of ADHD usually appear 
during the preschool/early elementary school years and 
Table 3: Mean and standard deviation of plaque index scores in 
ADHD children in the study groups.
 
 n Mean SD 
Ritalin treatment 36 39 9 
Neuro-feedback therapy 36 31 9 
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rarely later than early adolescence (22). ADHD conveys 
a risk for the development of dental anxiety, depressive 
and anxiety disorders as well as learning impairments, 
mood and language disorders (22,27). These conditions 
make the dental treatment time-consuming, costly and 
demanding for the clinician and the child, and have a 
strong negative impact on treatment outcome (27,28). 
ADHD children possess coping problems in challenging 
situations like dental setting owing to their impaired 
cognitive condition and higher rate of learning disorders 
(22,29). This highlights the importance of caries pre-
vention and selection of the treatment modality which 
does not compromise the oral health of ADHD children. 
Our results showed that USF in the ADHD children who 
were treated with Ritalin was significantly lower com-
pared to those who were treated with neuro-feedback 
therapy. In addition, the plaque index and dental caries 
were significantly higher in children receiving Ritalin. 
Although there is some inconsistency in the literature, 
most studies have revealed unhealthy oral status and 
higher caries among ADHD children (22,30,31). Four 
theories have been proposed with respect to the occu-
rrence of higher caries in children with ADHD. The 
nature of the illness itself results in poor oral hygiene; 
a cariogenic diet full of sugar which is consumed a lot 
by these patients; mouth dryness due to the side effects 
of medicines; and the lack of attention given by parents 
toward these children’s oral hygiene (32). In addition, 
previous research shows that fear, stress, and noncoo-
peration occurs in between 5.7% and 6.7% of children 
when attending the dentist, and this figure is higher in 
ADHD children which may prevent them from revisi-
ting the dentist and may be another important reason for 
their high dental caries (9,10,33).
USF in ADHD children undergoing treatment with Ri-
talin was significantly lower as compared to those un-
der the neuro-feedback treatment. Ritalin is an indirect 
Fig. 3: Mean and standard deviation of plaque index scores in ADHD 
children in the study groups.
agonist for dopamine and operates by preventing the 
dopamine from recapturing (1). Xerostomia, and redu-
ced secretion of saliva in the dental and oral section, 
are the most important side-effects of these medicines, 
which lead to extensive dental caries (13,14,32). A study 
by Medori et al. showed that Ritalin-based oral dryness 
is dose-dependent, and 8.11% of their patients reported 
mouth dryness. On the other hand, only 1.2% of subjects 
in placebo group reported dryness of mouth (18). 
In addition, reduced saliva flow in the ADHD children 
who use drugs may increase caries in these children 
(7,8). Similarly, drug-using children had higher dental 
caries in our study. In this line, Aminabadi et al. study 
(22) showed that children with ODD/ADHD had signi-
ficantly higher DMFT/dmft scores than normal children. 
Contrary to the results obtained in this paper, a study 
by Grooms et al. (2005) could not show a significant 
difference in terms of USF in children with ADHD using 
different medicines as compared to normal children. 
However, DMFS/dmfs was higher in this group than the 
control group (34). The reason behind this contradiction 
is the non-discrimination of children into drug users 
and non-drug users, which may affect the results. In ad-
dition, n a case-control study on children aged 11–13 
years, the consumption of drugs was related to a high 
DMFT in ADHD children. However, this study did not 
take medicine as a probable risk factor in dental caries. 
Also, this study was not reliable as it had a small sample 
size and only nine out of 14 ADHD children were under 
pharmacotherapy (35).
Furthermore, the age spectrum could be a confounding 
factor in obtaining contradictory results. For example, in 
a study by Blomqvist et al. (2007) on 13-year-old chil-
dren with ADHD, no significant difference was obser-
ved in terms of DMFT between normal and ADHD sub-
jects (30). Another study by Blomqvist et al. (2011) on 
17-year-old children showed that ADHD children had 
a higher DMFT than the control group (31). According 
to these studies, the underlying factor of caries in the 
freshly-grown teeth of ADHD children does not have 
sufficient opportunities to affect them. 
Aminabadi et al. study (22) showed that there was no 
significant difference in gingival index between children 
with ODD/ADHD and normal children. However, we 
found that the plaque index was higher in ADHD chil-
dren taking drugs, in addition to high DMFT and low 
USF which indicates the effects of USF on the accumu-
lation of plaque in the Ritalin-using group. It also may 
be the more serious effect of neuro-feedback therapy 
on controlling the behavioral problems of this group of 
children that improves their hygiene behaviors which re-
quires further studies. 
Generally, only two studies by Ariela Hidas (2011 and 
2012) analyzed the saliva and oral status of ADHD chil-
dren. It was done by separating them into subjects un-
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der pharmacotherapy and subjects undergoing no treat-
ment (13,14). In their study, although USF was lower in 
ADHD children than the normal ones, yet no significant 
difference was observed between two ADHD groups, in-
cluding those who took medicines and those without any 
treatment. Also, no significant difference was observed 
in terms of DMFT between the normal children, ADHD 
children under Ritalin treatment, and ADHD children 
not undergoing pharmacotherapy (14,17). An important 
difference between this study and the study by HIDAS 
is the higher number of samples and the longer duration 
of medication, which may affect the results. On the other 
hand, in this study, both the groups of patients were un-
der pharmacotherapy or neuro-feedback therapy for six 
months, which may reduce the intervening factor of 
treatment duration between the two groups. 
In overall, our results showed better oral health for 
ADHD children under neuro-feedback therapy which 
indicates the importance of therapies for ADHD children 
that are non-medicinal and less invasive. These types of 
treatments result in fewer dental and oral side effects in 
addition to the improvement of behavioral problems in 
ADHD children. Although the results of this study indi-
cate lower USF and higher PI in ADHD children under 
pharmacotherapy, because of the multitude of factors in-
fluencing dental caries and many intervening factors in 
this kind of study, further studies are required to make 
conclusions with certainty and resolve these contradic-
tions, specifically by using a bigger sample size and eli-
minating other influencing factors. 
Conclusions 
The results of this study showed that children with 
ADHD undergoing medical treatment by Methylpheni-
date (Ritalin) had lower unstimulated saliva flow (USF) 
index and higher DMFT and plaque index (PI) than 
ADHD children under neuro-feedback therapy. Therefo-
re, Neuro-feedback therapy is preferable to Ritalin treat-
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